Literature DB >> 6928681

Presence of cobalamin analogues in animal tissues.

H Kondo, J F Kolhouse, R H Allen.   

Abstract

Cobalamin (Cbl, vitamin B-12) has been extracted and isolated from a number of animal tissues by using (i) reverse-affinity chromatography on R protein-Sepharose followed by adsorption to and elution from charcoal-coated agarose and (ii) paper chromatography. Radioisotope dilution assays showed that only 75-97% of the Cbl chromatographed in the position of crystalline Cbl. The remaining 3-25% was present in a number of slower and faster moving fractions. This suggested that Cbl analogues are present in animal tissues because appropriate controls ruled out the possibility that this material was artifactually derived from Cbl during the extraction and purification procedures. With a large-scale isolation from rabbit kidney, the material in five such fractions contained cobalt and had absorption spectra that were similar to but different from the spectrum of Cbl, indicating that they were Cbl analogues. Compared to Cbl, these Cbl analogues had decreased but definite affinities for Cbl-binding proteins with the following order of strength of binding: R protein > transcobalamin II > intrinsic factor. Compared to Cbl, they also had decreased but definite growth-promoting activity for two microorganisms, Euglena gracilis and Lactobacillus leichmannii, which require Cbl for growth. These Cbl analogues differed from each other and from 18 synthetic Cbl analogues, including the most common Cbl analogues synthesized by microorganisms, in at least one of the above features. These studies indicate that animal tissues contain a number of Cbl analogues whose origins, structures, and biologic activities remain to be determined.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6928681      PMCID: PMC348372          DOI: 10.1073/pnas.77.2.817

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  15 in total

1.  New pigments derived from vitamin B12 by a strain of Aerobacter aerogenes present in river mud.

Authors:  K HELGELAND; J JONSEN; S LALAND
Journal:  Biochem J       Date:  1961-11       Impact factor: 3.857

2.  Biosynthesis of cobalamin analogues by propionibacterium arabinosum.

Authors:  D PERLAMN; J B BARRETT
Journal:  Can J Microbiol       Date:  1958-02       Impact factor: 2.419

3.  Evidence that some patients with pernicious anemia are not recognized by radiodilution assay for cobalamin in serum.

Authors:  B A Cooper; V M Whitehead
Journal:  N Engl J Med       Date:  1978-10-12       Impact factor: 91.245

Review 4.  The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins.

Authors:  G Ashwell; A G Morell
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1974

5.  Blockade of vitamin B12-binding sites in gastric juice, serum and saliva by analogues and derivatives of vitamin B12 and by antibody to intrinsic factor.

Authors:  C W Gottlieb; F P Retief; V Herbert
Journal:  Biochim Biophys Acta       Date:  1967-08-29

6.  Isolation of cobalamin and cobalamin analogs by reverse affinity chromatography.

Authors:  J F Kolhouse; R H Allen
Journal:  Anal Biochem       Date:  1978-02       Impact factor: 3.365

7.  Improved techniques for the extraction and chromatography of cobalamins.

Authors:  W A Fenton; L E Rosenberg
Journal:  Anal Biochem       Date:  1978-10-01       Impact factor: 3.365

8.  Absorption, plasma transport, and cellular retention of cobalamin analogues in the rabbit. Evidence for the existence of multiple mechanisms that prevent the absorption and tissue dissemination of naturally occurring cobalamin analogues.

Authors:  J F Kolhouse; R H Allen
Journal:  J Clin Invest       Date:  1977-12       Impact factor: 14.808

9.  Human plasma R-type vitamin B12-binding proteins. II. The role of transcobalamin I, transcobalamin III, and the normal granulocyte vitamin B12-binding protein in the plasma transport of vitamin B12.

Authors:  R L Burger; R J Schneider; C S Mehlman; R H Allen
Journal:  J Biol Chem       Date:  1975-10-10       Impact factor: 5.157

10.  Cobalamin analogues are present in human plasma and can mask cobalamin deficiency because current radioisotope dilution assays are not specific for true cobalamin.

Authors:  J F Kolhouse; H Kondo; N C Allen; E Podell; R H Allen
Journal:  N Engl J Med       Date:  1978-10-12       Impact factor: 91.245

View more
  6 in total

1.  Crohn's disease and vitamin B12 metabolism.

Authors:  D Lambert; S Benhayoun; C Adjalla; M A Gelot; P Renkes; F Felden; P Gerard; F Belleville; P Gaucher; J L Guéant; J P Nicolas
Journal:  Dig Dis Sci       Date:  1996-07       Impact factor: 3.199

2.  Inhibition of cobalamin-dependent enzymes by cobalamin analogues in rats.

Authors:  S P Stabler; E P Brass; P D Marcell; R H Allen
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

3.  Presence and formation of cobalamin analogues in multivitamin-mineral pills.

Authors:  H Kondo; M J Binder; J F Kolhouse; W R Smythe; E R Podell; R H Allen
Journal:  J Clin Invest       Date:  1982-10       Impact factor: 14.808

4.  Nitrous oxide has multiple deleterious effects on cobalamin metabolism and causes decreases in activities of both mammalian cobalamin-dependent enzymes in rats.

Authors:  H Kondo; M L Osborne; J F Kolhouse; M J Binder; E R Podell; C S Utley; R S Abrams; R H Allen
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

5.  Accurate assessment and identification of naturally occurring cellular cobalamins.

Authors:  Luciana Hannibal; Armend Axhemi; Alla V Glushchenko; Edward S Moreira; Nicola E Brasch; Donald W Jacobsen
Journal:  Clin Chem Lab Med       Date:  2008       Impact factor: 3.694

6.  Molecular Pathways and Pigments Underlying the Colors of the Pearl Oyster Pinctada margaritifera var. cumingii (Linnaeus 1758).

Authors:  Pierre-Louis Stenger; Chin-Long Ky; Céline Reisser; Julien Duboisset; Hamadou Dicko; Patrick Durand; Laure Quintric; Serge Planes; Jeremie Vidal-Dupiol
Journal:  Genes (Basel)       Date:  2021-03-15       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.